Compare PayPal Holdings, Inc. (PYPL) vs TG Therapeutics Inc (TGTX) Price & Performance

PayPal (PYPL) trades at $55.02, up 0.13% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a P/E of 10.4, net income margin of 14.36%, and recent earnings beats. Recent news highlights a Meta partnership for AI-powered checkout, potentially driving growth. Cash flow remains healthy with $1.53B net cash flow in 2025.

PYPL presents a value opportunity with attractive valuation multiples and solid profitability, though competition in digital payments and slowing branded checkout growth pose risks. Analyst consensus is mixed with a $56.41 price target, suggesting modest upside from current levels. The Meta partnership and cost-cutting initiatives under new CEO Enrique Lores provide catalysts for potential re-rating.

TG Therapeutics (TGTX) trades at $53.34, up 0.74% today, but faces bearish technical signals despite strong profitability metrics like a 55.22% net income margin. Recent earnings misses and a shareholder investigation create headwinds, though revenue growth and a high analyst buy consensus of 84.62% suggest underlying strength. The stock's current price is near key support at $52, with resistance at $54.

The outlook is mixed: robust revenue growth and institutional buying support upside toward the $80.50 consensus target, but earnings misses and legal risks pose challenges. Investors should weigh the company's MS therapy momentum against execution and regulatory uncertainties for balanced risk-reward assessment.